Hicerin Capsule contains Diacerein 50 mg, a slow-acting symptomatic agent primarily used in the management of osteoarthritis. Diacerein is an anthraquinone derivative that exhibits anti-inflammatory and chondroprotective properties by inhibiting interleukin-1 beta (IL-1β), a key mediator in cartilage degradation and inflammation. This mechanism helps reduce joint pain and improve joint function in patients with osteoarthritis. Hicerin is indicated for symptomatic treatment of osteoarthritis affecting the knee, hip, and other joints. It may be used as part of a comprehensive management plan including physical therapy and lifestyle modifications. The capsule formulation allows for oral administration, with absorption occurring in the gastrointestinal tract. Common adverse effects include mild gastrointestinal disturbances such as diarrhea, abdominal pain, and soft stools, which are generally transient and dose-dependent. Use of Hicerin should be avoided in patients with hepatic or renal impairment, inflammatory bowel disease, or a history of bowel obstruction. Caution is advised in elderly patients and those on concomitant medications. Regular monitoring of liver function tests is recommended during prolonged therapy. Hicerin Capsule should be used under medical supervision to optimize therapeutic outcomes and minimize potential risks.